- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03781037
Targeting Burdensomeness Among Clinic Referred Youth
12 mai 2021 mis à jour par: Florida International University
This study will develop and pilot test a novel intervention module targeting perceived burdensomeness toward others in 30 clinic referred youths who experience anxiety or depression and elevated levels of burdensomeness.
All participants will be assigned to receive the intervention in this open trial.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Suicidal ideation is prevalent and impairing in youth, with approximately 15% of high school students reporting seriously considering a suicide attempt and making a specific plan for suicide in the past 12 months.
Substantial evidence documents perceived burdensomeness towards others, or the belief that one is a burden or drain on others, as a risk factor for suicide ideation in youth.
This evidence highlights the potential promise of perceived burdensomeness as a novel intervention target to prevent suicide ideation in youth.
The current study will develop and preliminary evaluate a novel, brief behavioral treatment module targeting perceived burdensomeness in youth that can be embedded within existing psychosocial treatments.
The study will use an open trial design.
The first aim of this proposal is to develop a novel, brief psychosocial intervention module (the GIVE module) targeting perceived burdensomeness towards others that can be embedded within existing CBT protocols for youth internalizing problems.
The second aim is to collect data relevant to client satisfaction and reductions in perceived burdensomeness.
Participants will be N=30 clinic-referred youth ages 10 to 17 years with anxiety or depressive disorders in a university-based research clinic, who display elevated levels of perceived burdensomeness.
In the context on ongoing CBT for anxiety or depression, participants will complete the GIVE module at sessions 6 and 7 of the CBT protocol.
It is hypothesized that perceived burdensomeness will be significantly lower after the GIVE module is administered, and that client satisfaction will be high.
Data collected in this study will provide the foundation for a subsequent randomized controlled trial of the GIVE module.
Type d'étude
Interventionnel
Inscription (Réel)
18
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Florida
-
Miami, Florida, États-Unis, 33199
- Florida International University Center for Children and Families
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
10 ans à 17 ans (Enfant)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Clinical diagnosis of an anxiety disorder, persistent depressive disorder, or major depressive disorder
- Score > 4 on the youth self-report Interpersonal Needs Questionnaire- Perceived Burdensomeness Scale
Exclusion Criteria:
- Clinical diagnosis of a Psychotic Disorder, Autism Spectrum Disorder or Intellectual Disability
- Show high risk of imminent self-injurious behaviors
- Be involved currently in another behavioral treatment
- Not live with a primary caregiver who is legally able to give consent for the youth's participation
- Be a victim of previously undisclosed abuse requiring investigation or ongoing supervision by the Department of Children and Families.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: GIVE module
The GIVE module consists of one 50-minute treatment session and a second partial session (15-20 minutes) embedded within a larger cognitive behavioral treatment (CBT) protocol for anxiety or depression.
The GIVE module uses cognitive behavioral principles to target youth's beliefs that they are a burden or drain on others.
|
The GIVE Module is a brief cognitive behavioral intervention targeting youths' beliefs that they are a burden or drain on others.
It consists of two sessions embedded within a larger CBT protocol for anxiety or depression.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
6-item Youth Perceived Burdensomeness Subscale of the Interpersonal Needs Questionnaire
Délai: post-intervention (within one week of completing the GIVE Module)
|
Youth self-ratings on perceived burdensomeness over the past week.
Each item is scored 1-7 (1 = not at all true for me; 7 = very true for me), yielding a total between 6 and 42.
Higher scores indicate higher levels of perceived burdensomeness (worse outcome).
|
post-intervention (within one week of completing the GIVE Module)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
10-item Youth Rated Warmth Subscale of the Child Report of Parental Behavior Inventory
Délai: post-intervention (within one week of completing the GIVE Module)
|
Youth ratings on parental warmth over the past week.
Each of 10 items is scored 1-3 (1 = not like parent; 3 = a lot like parent), yielding a total score of 10 to 30.
Higher scores indicate higher levels of parental warmth (better outcome).
|
post-intervention (within one week of completing the GIVE Module)
|
10-item Parent Rated Warmth Subscale of the Parent Report of Parental Behavior Inventory
Délai: post-intervention (within one week of completing the GIVE Module)
|
Parent self-ratings on parental warmth over the past week.
Each of 10 items is scored 1-3 (1 = not like me; 3 = a lot like me), yielding a total score of 10 to 30.
Higher scores indicate higher levels of parental warmth (better outcome).
|
post-intervention (within one week of completing the GIVE Module)
|
41-item Youth Rated Screen for Child Anxiety Related Emotional Disorders
Délai: post-intervention (within one week of completing the GIVE Module)
|
Youth self-ratings on anxiety symptom severity.
Each item is scored 0-2 (0 = not true; 2 = very true), yielding a total score of 0 to 82.
Higher scores indicate higher levels of anxiety (worse outcome).
|
post-intervention (within one week of completing the GIVE Module)
|
41-item Parent Rated Screen for Child Anxiety Related Emotional Disorders
Délai: post-intervention (within one week of completing the GIVE Module)
|
Parent ratings on youth anxiety symptom severity.
Each item is scored 0-2 (0 = not true; 2 = very true), yielding a total score of 0 to 82.
Higher scores indicate higher levels of anxiety (worse outcome).
|
post-intervention (within one week of completing the GIVE Module)
|
28-item Youth-rated Children's Depression Inventory - 2
Délai: post-intervention (within one week of completing the GIVE Module)
|
Youth self-ratings on depressive symptom severity.
Each item is scored 0-2, yielding total scores of 0 to 56, with higher scores corresponding to more severe symptoms.
|
post-intervention (within one week of completing the GIVE Module)
|
17-item Parent Rated Children's Depression Inventory - 2
Délai: post-intervention (within one week of completing the GIVE Module)
|
Parent ratings on youth depressive symptom severity.
Each item is scored 0-3, yielding total scores of 0 to 51, with higher scores corresponding to more severe symptoms.
|
post-intervention (within one week of completing the GIVE Module)
|
8-item Youth Rated Client Satisfaction Questionnaire
Délai: post-intervention (within one week of completing the GIVE Module)
|
Youth ratings of satisfaction with the GIVE module.
Each item is score 1-4 (1 = quite dissatisfied; 4 = very satisfied), yielding total scores of 8-32.
Higher scores indicate higher satisfaction (better outcome).
|
post-intervention (within one week of completing the GIVE Module)
|
8-item Parent Rated Client Satisfaction Questionnaire
Délai: post-intervention (within one week of completing the GIVE Module)
|
Parent ratings of satisfaction with the GIVE module.
Each item is score 1-4 (1 = quite dissatisfied; 4 = very satisfied), yielding total scores of 8-32.
|
post-intervention (within one week of completing the GIVE Module)
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
20 mars 2019
Achèvement primaire (Réel)
30 décembre 2020
Achèvement de l'étude (Réel)
30 décembre 2020
Dates d'inscription aux études
Première soumission
18 décembre 2018
Première soumission répondant aux critères de contrôle qualité
18 décembre 2018
Première publication (Réel)
19 décembre 2018
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
8 juin 2021
Dernière mise à jour soumise répondant aux critères de contrôle qualité
12 mai 2021
Dernière vérification
1 mai 2021
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 1F31MH116603 (Subvention/contrat des NIH des États-Unis)
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .